EXR
42
5
DE
49
3
MET
58
2
UNP
38
5
T
32
2
LRCX
56
4
MAR
57
3
GS
65
16
JBHT
46
4
JWN
72
9
A
43
2
HBI
53
4
SLB
41
2
CME
59
3
CF
47
5
GOOGL
62
6
HRB
40
3
O
26
16
BEN
36
4
CI
35
2
EXR
42
5
DE
49
3
MET
58
2
UNP
38
5
T
32
2
LRCX
56
4
MAR
57
3
GS
65
16
JBHT
46
4
JWN
72
9
A
43
2
HBI
53
4
SLB
41
2
CME
59
3
CF
47
5
GOOGL
62
6
HRB
40
3
O
26
16
BEN
36
4
CI
35
2
Financhill
Back

NovaBay Pharmaceuticals Quote, Financials, Valuation and Earnings

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
19

NBY
NovaBay Pharmaceuticals

Last Price:
$0.53
Seasonality Move:
-0.66%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.

NovaBay Pharmaceuticals Price Quote

$0.53
+0.00 (+5.14%)
(Updated: December 21, 2024 at 5:38 AM ET)

NovaBay Pharmaceuticals Key Stats

Sell
19
NovaBay Pharmaceuticals (NBY) is a Sell
Day range:
$0.50 - $0.53
52-week range:
$0.36 - $9.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.06
P/B ratio:
2.43%
Volume:
514.1K
Avg. volume:
111K
1-year change:
-94.45%
Market cap:
$2.6M
Revenue:
$14.7M
EPS:
$-35.8

How Much Does NovaBay Pharmaceuticals Make?

Data Unavailable

Is NovaBay Pharmaceuticals Growing As A Company?

Data Unavailable

NovaBay Pharmaceuticals Stock Price Performance

What Is NovaBay Pharmaceuticals 52-Week High & Low?

NovaBay Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NovaBay Pharmaceuticals?

Data Unavailable

Is NovaBay Pharmaceuticals Cash Flow Positive?

Data Unavailable

NovaBay Pharmaceuticals Return On Invested Capital

Data Unavailable

NovaBay Pharmaceuticals Earnings Date & Stock Price

NovaBay Pharmaceuticals Competitors

NovaBay Pharmaceuticals Dividend Yield

Data Unavailable

NovaBay Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -94.78%
Revenue: -1.61% -7.01%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable